The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Jet Lag Medicine Market Research Report 2025
Synopsis
The global Jet Lag Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Jet Lag Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Jet Lag Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Jet Lag Medicine include Miers Laboratories, No-Jet-Lag, Natrol, Teva, The Vitamin Shoppe, Sisu, Trip Ease, Holland & Barrett and Superdrug, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Jet Lag Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Jet Lag Medicine.
Report Scope
The Jet Lag Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Jet Lag Medicine market comprehensively. Regional market sizes, concerning products by Type, by Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Jet Lag Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Channel, and by regions.
Market Segmentation
By Company
Miers Laboratories
No-Jet-Lag
Natrol
Teva
The Vitamin Shoppe
Sisu
Trip Ease
Holland & Barrett
Superdrug
Jetease
Nature’s Bounty
Boiron
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Segment by Type
Prescription
OTC
Segment by Channel
Offline Sales
Online Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Jet Lag Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Jet Lag Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Jet Lag Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Jet Lag Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Jet Lag Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Jet Lag Medicine include Miers Laboratories, No-Jet-Lag, Natrol, Teva, The Vitamin Shoppe, Sisu, Trip Ease, Holland & Barrett and Superdrug, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Jet Lag Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Jet Lag Medicine.
Report Scope
The Jet Lag Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Jet Lag Medicine market comprehensively. Regional market sizes, concerning products by Type, by Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Jet Lag Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Channel, and by regions.
Market Segmentation
By Company
Miers Laboratories
No-Jet-Lag
Natrol
Teva
The Vitamin Shoppe
Sisu
Trip Ease
Holland & Barrett
Superdrug
Jetease
Nature’s Bounty
Boiron
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Segment by Type
Prescription
OTC
Segment by Channel
Offline Sales
Online Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Jet Lag Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Jet Lag Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Jet Lag Medicine Market Overview
1.1 Product Overview and Scope of Jet Lag Medicine
1.2 Jet Lag Medicine Segment by Type
1.2.1 Global Jet Lag Medicine Market Value Comparison by Type (2024-2030)
1.2.2 Prescription
1.2.3 OTC
1.3 Jet Lag Medicine Segment by Channel
1.3.1 Global Jet Lag Medicine Market Value by Channel: (2024-2030)
1.3.2 Offline Sales
1.3.3 Online Sales
1.4 Global Jet Lag Medicine Market Size Estimates and Forecasts
1.4.1 Global Jet Lag Medicine Revenue 2019-2030
1.4.2 Global Jet Lag Medicine Sales 2019-2030
1.4.3 Global Jet Lag Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Jet Lag Medicine Market Competition by Manufacturers
2.1 Global Jet Lag Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Jet Lag Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Jet Lag Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Jet Lag Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Jet Lag Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Jet Lag Medicine, Product Type & Application
2.7 Jet Lag Medicine Market Competitive Situation and Trends
2.7.1 Jet Lag Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Jet Lag Medicine Players Market Share by Revenue
2.7.3 Global Jet Lag Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Jet Lag Medicine Retrospective Market Scenario by Region
3.1 Global Jet Lag Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Jet Lag Medicine Global Jet Lag Medicine Sales by Region: 2019-2030
3.2.1 Global Jet Lag Medicine Sales by Region: 2019-2024
3.2.2 Global Jet Lag Medicine Sales by Region: 2025-2030
3.3 Global Jet Lag Medicine Global Jet Lag Medicine Revenue by Region: 2019-2030
3.3.1 Global Jet Lag Medicine Revenue by Region: 2019-2024
3.3.2 Global Jet Lag Medicine Revenue by Region: 2025-2030
3.4 North America Jet Lag Medicine Market Facts & Figures by Country
3.4.1 North America Jet Lag Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Jet Lag Medicine Sales by Country (2019-2030)
3.4.3 North America Jet Lag Medicine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Jet Lag Medicine Market Facts & Figures by Country
3.5.1 Europe Jet Lag Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Jet Lag Medicine Sales by Country (2019-2030)
3.5.3 Europe Jet Lag Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Jet Lag Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Jet Lag Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Jet Lag Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Jet Lag Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Jet Lag Medicine Market Facts & Figures by Country
3.7.1 Latin America Jet Lag Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Jet Lag Medicine Sales by Country (2019-2030)
3.7.3 Latin America Jet Lag Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Jet Lag Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Jet Lag Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Jet Lag Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Jet Lag Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Jet Lag Medicine Sales by Type (2019-2030)
4.1.1 Global Jet Lag Medicine Sales by Type (2019-2024)
4.1.2 Global Jet Lag Medicine Sales by Type (2025-2030)
4.1.3 Global Jet Lag Medicine Sales Market Share by Type (2019-2030)
4.2 Global Jet Lag Medicine Revenue by Type (2019-2030)
4.2.1 Global Jet Lag Medicine Revenue by Type (2019-2024)
4.2.2 Global Jet Lag Medicine Revenue by Type (2025-2030)
4.2.3 Global Jet Lag Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Jet Lag Medicine Price by Type (2019-2030)
5 Segment by Channel
5.1 Global Jet Lag Medicine Sales by Channel (2019-2030)
5.1.1 Global Jet Lag Medicine Sales by Channel (2019-2024)
5.1.2 Global Jet Lag Medicine Sales by Channel (2025-2030)
5.1.3 Global Jet Lag Medicine Sales Market Share by Channel (2019-2030)
5.2 Global Jet Lag Medicine Revenue by Channel (2019-2030)
5.2.1 Global Jet Lag Medicine Revenue by Channel (2019-2024)
5.2.2 Global Jet Lag Medicine Revenue by Channel (2025-2030)
5.2.3 Global Jet Lag Medicine Revenue Market Share by Channel (2019-2030)
5.3 Global Jet Lag Medicine Price by Channel (2019-2030)
6 Key Companies Profiled
6.1 Miers Laboratories
6.1.1 Miers Laboratories Corporation Information
6.1.2 Miers Laboratories Description and Business Overview
6.1.3 Miers Laboratories Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Miers Laboratories Jet Lag Medicine Product Portfolio
6.1.5 Miers Laboratories Recent Developments/Updates
6.2 No-Jet-Lag
6.2.1 No-Jet-Lag Corporation Information
6.2.2 No-Jet-Lag Description and Business Overview
6.2.3 No-Jet-Lag Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 No-Jet-Lag Jet Lag Medicine Product Portfolio
6.2.5 No-Jet-Lag Recent Developments/Updates
6.3 Natrol
6.3.1 Natrol Corporation Information
6.3.2 Natrol Description and Business Overview
6.3.3 Natrol Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Natrol Jet Lag Medicine Product Portfolio
6.3.5 Natrol Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Jet Lag Medicine Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 The Vitamin Shoppe
6.5.1 The Vitamin Shoppe Corporation Information
6.5.2 The Vitamin Shoppe Description and Business Overview
6.5.3 The Vitamin Shoppe Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 The Vitamin Shoppe Jet Lag Medicine Product Portfolio
6.5.5 The Vitamin Shoppe Recent Developments/Updates
6.6 Sisu
6.6.1 Sisu Corporation Information
6.6.2 Sisu Description and Business Overview
6.6.3 Sisu Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sisu Jet Lag Medicine Product Portfolio
6.6.5 Sisu Recent Developments/Updates
6.7 Trip Ease
6.6.1 Trip Ease Corporation Information
6.6.2 Trip Ease Description and Business Overview
6.6.3 Trip Ease Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Trip Ease Jet Lag Medicine Product Portfolio
6.7.5 Trip Ease Recent Developments/Updates
6.8 Holland & Barrett
6.8.1 Holland & Barrett Corporation Information
6.8.2 Holland & Barrett Description and Business Overview
6.8.3 Holland & Barrett Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Holland & Barrett Jet Lag Medicine Product Portfolio
6.8.5 Holland & Barrett Recent Developments/Updates
6.9 Superdrug
6.9.1 Superdrug Corporation Information
6.9.2 Superdrug Description and Business Overview
6.9.3 Superdrug Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Superdrug Jet Lag Medicine Product Portfolio
6.9.5 Superdrug Recent Developments/Updates
6.10 Jetease
6.10.1 Jetease Corporation Information
6.10.2 Jetease Description and Business Overview
6.10.3 Jetease Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jetease Jet Lag Medicine Product Portfolio
6.10.5 Jetease Recent Developments/Updates
6.11 Nature’s Bounty
6.11.1 Nature’s Bounty Corporation Information
6.11.2 Nature’s Bounty Jet Lag Medicine Description and Business Overview
6.11.3 Nature’s Bounty Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nature’s Bounty Jet Lag Medicine Product Portfolio
6.11.5 Nature’s Bounty Recent Developments/Updates
6.12 Boiron
6.12.1 Boiron Corporation Information
6.12.2 Boiron Jet Lag Medicine Description and Business Overview
6.12.3 Boiron Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Boiron Jet Lag Medicine Product Portfolio
6.12.5 Boiron Recent Developments/Updates
6.13 Genexa
6.13.1 Genexa Corporation Information
6.13.2 Genexa Jet Lag Medicine Description and Business Overview
6.13.3 Genexa Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Genexa Jet Lag Medicine Product Portfolio
6.13.5 Genexa Recent Developments/Updates
6.14 Homeocan
6.14.1 Homeocan Corporation Information
6.14.2 Homeocan Jet Lag Medicine Description and Business Overview
6.14.3 Homeocan Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Homeocan Jet Lag Medicine Product Portfolio
6.14.5 Homeocan Recent Developments/Updates
6.15 Clinigen Group
6.15.1 Clinigen Group Corporation Information
6.15.2 Clinigen Group Jet Lag Medicine Description and Business Overview
6.15.3 Clinigen Group Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Clinigen Group Jet Lag Medicine Product Portfolio
6.15.5 Clinigen Group Recent Developments/Updates
6.16 Vanda Pharma
6.16.1 Vanda Pharma Corporation Information
6.16.2 Vanda Pharma Jet Lag Medicine Description and Business Overview
6.16.3 Vanda Pharma Jet Lag Medicine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Vanda Pharma Jet Lag Medicine Product Portfolio
6.16.5 Vanda Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Jet Lag Medicine Industry Chain Analysis
7.2 Jet Lag Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Jet Lag Medicine Production Mode & Process
7.4 Jet Lag Medicine Sales and Marketing
7.4.1 Jet Lag Medicine Sales Channels
7.4.2 Jet Lag Medicine Distributors
7.5 Jet Lag Medicine Customers
8 Jet Lag Medicine Market Dynamics
8.1 Jet Lag Medicine Industry Trends
8.2 Jet Lag Medicine Market Drivers
8.3 Jet Lag Medicine Market Challenges
8.4 Jet Lag Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
